Lifesaving drugs caught up in ‘funding logjam’

Lifesaving drugs have been caught up in a funding logjam as the HSE fears the cost involved could adversely affect existing services.

Lifesaving drugs caught up in ‘funding logjam’
Fri, 28 Jul, 2017 - 01:00
Evelyn Ring

Nine new hi-tech drugs were recommended for approval by the HSE, subject to additional funding being provided.

The drugs include new treatments for cancer and heart conditions. The HSE confirmed the cost over five years would be around €117m.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

‘I’ve lived here my whole life but still fell through the cracks’ ‘I’ve lived here my whole life but still fell through the cracks’
Bealtaine Fire Festival Bealtaine celebrations take place on the Hill of Uisneach in Co Westmeath
Drug intimidation 'pervasive' across all counties – report Drug intimidation 'pervasive' across all counties – report
CourtsDrugsFundingHSECostPlace: South Tipperary General HospitalPlace: IrelandPlace: EuropePerson: Minister for HealthPerson: Simon HarrisPerson: Alan KellyPerson: EntrestoPerson: Niall ColwellPerson: ColwellPerson: Oliver O’ConnorPerson: O’ConnorPerson: GazyvaroPerson: ErivedgeOrganisation: HSEOrganisation: Department of HealthOrganisation: Labour PartyOrganisation: RTÉ RadioOrganisation: Irish Pharmaceutical Healthcare AssociationOrganisation: IPHA
<p>Minister for Justice Jim O’Callaghan at Fianna Fáil’s annual Sean Lemass Commemoration on Sunday, May 10 2026. At the graveside of the former Taoiseach in Deansgrange Cemetery, Dun Laoghaire. (Bairbre Holmes/PA)</p>

Minister mulling plan for payments to Ukrainian refugees after they return home

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited